Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1
Review
![](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
19,851 | Dovepress* | 15,479+ | 2,600 | 18,079 | |
PubMed Central* | 4,372 | 848 | 5,220 | ||
Totals | 19,851 | 3,448 | 23,299 | ||
*Since 10 November 2010 +Since July 2016 |
View citations on PubMed Central and Google Scholar